Article Text

PDF
AB0418 Differences between clinical and laboratory findings in patients with recent diagnosis of sle according to the presence or absence of anti-dna antibodies by crithidia luciliae
  1. M. I. Sarbu1,
  2. P. Rubio Muñoz1,
  3. T. C. Salman Monte1,
  4. J. G. Lopéz Velandia1,
  5. J. Pérez-Ruiz1,
  6. A. P. Cacheda1,
  7. J. Carbonell Abelló1
  1. 1Rheumatology, HOSPITAL DEL MAR, BARCELONA, Spain

Abstract

Objectives To evaluate if the existence of anti-dsDNA antibodies detected by Crithidia luciliae indirect immunofluorescence (CLIF) method is associated with clinical and laboratory differences in patients with recent diagnosis of SLE.

Methods Retrospective descriptive study of a group of 104 SLE patients (who fulfilled the ACR 1982 revised criteria) with diagnostic and follow-up in our center. After consulting the clinical histories of the patients we recorded and analyzed: demographic data (age, sex and race), clinical manifestations (articular and extra-articular like malar rash, photosensitivity, discoid lupus, oral ulcers, diffuse alopecia, serositis, neurological, hematological and renal involvement) and laboratory parameters (ESR-mm/h, PCR-mg/dl, C3-mg/dl, C4-mg/dl, DNA-UI/mL, ANA titer, leukocyte, lymphocyte and neutrophil count-x10^3/ul, 24 hour proteinuria-mg/24h). We divided the patients in 3 groups based on the presence of anti-dsDNA by CLIF as follows: Group 1-CLIF always negative, Group 2-positive for CLIF at baseline, Group 3-positive for CLIF sometime during follow-up.

Results Of the 104 patients analyzed 97.1% were women with a mean age at the time of the diagnosis of 42,1±15,4 years. Twenty-nine patients (27.9%) were positive for anti-dsDNA CLIF at baseline (group 2) and 12 (11.5%) during follow-up (group 3). The patients who were positive for anti-dsDNA by CLIF at baseline showed higher titers of anti-dsDNA by ELISA and ANA antibodies, more lymphopenia and complement consumption, statistically significant when compared with the other two groups (p< 0.05). Regarding the clinical manifestations, the patients positive for anti-dsDNA by CLIF (groups 2 and 3) presented with more arthritis at baseline (p = 0.005). (see table).

Conclusions The results of this study suggest that the patients with SLE with positive anti-dsDNA by CLIF have more active disease presenting more lymphopenia and complement consumption. In our study population the baseline and follow-up positivity for anti-dsDNA by CLIF was associated to more arthritis at the beginning of the disease.

Acknowledgements Sergi Mojal

Disclosure of Interest None Declared

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.